Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe ma

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype

Although RTS,S remains the most advanced malaria vaccine, the factors influencing differences in vac

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review

Abstract Introduction In malaria‐stricken regions, malaria continues to be one of the primary cau

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children

Background

The RTS,S/AS01 malaria vaccine candidate is being evaluated for implementati

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries

Background The RTS,S/ASO1 E